Efficacy of treatment with brodalumab after treatment failure of previous interleukin 17A inhibitors in patients with psoriasis

被引：0
|
作者：
Loft, Nikolai [1 ,2 ]
Bregnhoj, Anne [3 ]
Fage, Simon [3 ]
Nielsen, Claus Henrik [4 ]
Enevold, Christian [4 ]
Zachariae, Claus [1 ,2 ,3 ]
Iversen, Lars [3 ]
Skov, Lone [1 ,2 ]
机构：
[1] Univ Copenhagen, Herlev & Gentofte Hosp, Dept Dermatol & Allergy, Hellerup, Denmark
[2] Herlev & Gentofte Hosp, Copenhagen Res Grp Inflammatory Skin, Hellerup, Denmark
[3] Aarhus Univ Hosp, Dept Dermatol, Aarhus, Denmark
[4] Copenhagen Univ Hosp, Rigshosp, Inst Inflammat Res, Ctr Rheumatol & Spine Dis, Copenhagen, Denmark
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2021年 / 85卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
26580
引用
收藏
页码：AB107 / AB107
页数：1
相关论文
共 50 条
  • [41] Interleukin-17 inhibitors for the treatment of ankylosing spondylitis
    Huang, Jin-Xian
    Zhang, Li-Jun
    Wei, James Cheng-Chung
    RHEUMATOLOGY AND IMMUNOLOGY RESEARCH, 2020, 1 (01): : 25 - 29
  • [42] Long-term clinical safety and efficacy of brodalumab in the treatment of Japanese patients with moderate-to-severe plaque psoriasis
    Umezawa, Y.
    Nakagawa, H.
    Niiro, H.
    Ootaki, K.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 (11) : 1957 - 1960
  • [43] A NETWORK META-ANALYSIS TO EVALUATE THE EFFICACY OF BRODALUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE PSORIASIS
    Sawyer, L.
    Fotheringham, I
    Wright, E.
    Bermingham, S.
    Gibbons, C.
    Moller, A. H.
    Marques, R.
    VALUE IN HEALTH, 2017, 20 (09) : A801 - A801
  • [44] Efficacy of brodalumab in the treatment of scalp and nail psoriasis: results from three phase 3 trials
    Elewski, Boni
    Rich, Phoebe
    Lain, Edward
    Soung, Jennifer
    Lewitt, George Michael
    Jacobson, Abby
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (01) : 261 - 265
  • [45] Interleukin 17A as an Effective Target for Anti-inflammatory and Antiparasitic Treatment of Toxoplasmic Uveitis
    Sauer, Arnaud
    Pfaff, Alexander W.
    Villard, Odile
    Creuzot-Garcher, Catherine
    Dalle, Frederic
    Chiquet, Christophe
    Pelloux, Herve
    Speeg-Schatz, Claude
    Gaucher, David
    Prevost, Gilles
    Bourcier, Tristan
    Candolfi, Ermanno
    JOURNAL OF INFECTIOUS DISEASES, 2012, 206 (08): : 1319 - 1329
  • [46] Drug survival of interleukin 17 inhibitors after switch from interleukin 23 inhibitors in psoriasis: An observational cohort study
    Kushnir-Grinbaum, Daniella
    Ziv, Michael
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (06) : 1260 - 1263
  • [47] Efficacy and safety of switching to ixekizumab in secukinumab nonresponders with plaque psoriasis: A multicenter retrospective study of interleukin 17A antagonist therapies
    Georgakopoulos, Jorge R.
    Phung, Michelle
    Ighani, Arvin
    Yeung, Jensen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (01) : 155 - 157
  • [48] Brief Report Relevance of Inflammatory Cytokine mRNA Expression of Tumour Necrosis Factor- Alpha (TNF α), Interleukin 17A (IL 17A) and Interleukin 6 (IL 6) in Indian Patients with Psoriasis
    Shah, Saiqa R.
    Shaikh, Sadiya B.
    Bhandary, Yashodhar P.
    Yassir, Shaheena
    Shenoy, Manjunath M.
    INDIAN DERMATOLOGY ONLINE JOURNAL, 2022, 13 (02) : 229 - 233
  • [49] Updated review of IL-17 inhibitors for psoriasis treatment
    Ni Lian
    Min Chen
    国际皮肤性病学杂志（英文）, 2018, 1 (03) : 157 - 163
  • [50] Interleukin-17A Inhibitors in Patients with Psoriasis and Tuberculosis Infection: A 2-Year Prospective Study on Safety Without Preventive Treatment
    Chun-Xia He
    Chao Wu
    Li Zhang
    Hong-Zhong Jin
    Dermatology and Therapy, 2024, 14 : 893 - 906
12345